VictorYoussefYazbeckMD, MS

PubMed

• 17 citations
  Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas.
  Beata Holkova, Maciej Kmieciak, Prithviraj Bose, Victor Yazbeck, Paul M. Barr
  Leukemia & Lymphoma. 2016-03-03
• 18 citations
  Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cells
  Victor Y. Yazbeck, Changyou Li, Jennifer R. Grandis, Yan Zang, Daniel Johnson
  Oral Oncology. 2014-02-01
• 38 citations
  Marginal Zone Lymphoma: State-of-the-Art Treatment
  Ariel Sindel, Taha Al-Juhaishi, Victor Yazbeck
  Current Treatment Options in Oncology. 2019-12-05

Abstracts/Posters

• Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged _60 YearsClinically Relevant Abstract
  Victor Yazbeck, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-Cell Lymphoma (PTCL) in Adults Age 60 and Above
  Victor Yazbeck, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes
  Victor Yazbeck, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019